Explore more publications!

Nano Dimension Announces Financial Results for the Fourth Quarter and Full Year 2025

Full-Year 2025 revenue of $102.4 million, a 77.3% increase over the prior-year period 

Company Continues to Drive Meaningful Cost Reductions

Company Issues Full Year 2026 Financial Guidance

Strategic Alternatives Review Advancing with Clear Path Forward Expected in Q2

WALTHAM, Mass., March 31, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, “Nano”, or the “Company”), a leader in digital manufacturing solutions, today announced financial results for the fourth quarter and full year ended December 31, 2025.

The consolidated results incorporate the financial position and performance of Markforged Holding Corporation (“Markforged”) from the acquisition date of April 25, 2025. Desktop Metal, Inc. (“Desktop Metal”) was acquired by the Company on April 2, 2025. The results of Desktop Metal from April 2, 2025 through July 28, 2025 as well as impairment charges related to the Desktop Metal assets and the costs associated with the bankruptcy and deconsolidation are included in Discontinued Operations on the Consolidated Statement of Operations.

Fourth Quarter 2025 Results:

  • Revenue: $35.3 million, a 142.4% increase from $14.6 million year-over-year
  • Gross Margin (“GM”): 37.7%, up from 32.9% year-over-year
  • Adjusted Gross Margin (“Adjusted GM”): 49.7%, up from 36.3% year-over-year
  • Adjusted EBITDA loss: $9.8 million, down from a loss of $18.9 million year-over-year
  • Net Loss from Continuing Operations: $33.9 million, up from a loss of $9.3 million year-over-year
  • Total cash, cash equivalents, deposits and marketable equity securities: $459.6 million as of December 31, 2025, down from $515.5 million as of September 30, 2025. This change of approximately $55.9 million includes $19.8 million of cash used for share repurchases during the quarter and $24.4 million related to changes in the fair value of marketable equity securities.

Full Year 2025 Results:

  • Revenue: $102.4 million, a 77.3% increase from $57.8 million year-over-year
  • GM: 33.5%, down from 43.1% year-over-year
  • Adjusted GM: 46.9%, up from 45.4% year-over-year
  • Adjusted EBITDA loss: $53.2 million, down from a loss of $63.6 million year-over-year
  • Net Loss from Continuing Operations: $100.4 million, up from a loss of $99.9 million year-over-year

More information, including a reconciliation of Adjusted EBITDA and Adjusted Gross Margin to the most directly comparable GAAP financial measure can be found below in this press release under “Non-GAAP Financial Measures” and “Reconciliation of US GAAP to Non-GAAP Measures.”

David Stehlin, Chief Executive Officer, commented, “We delivered a strong finish to 2025, exceeding our fourth-quarter top and bottom line financial guidance. As we move through 2026, we are building on this momentum by continuing to drive operational discipline, reduce our cost structure and lower cash burn across the business. Our focus remains on executing these actions to create value for our shareholders.”

Recent Developments

  • Operating Discipline and Cost Savings: During 2025, the Company made meaningful progress driving cost savings by streamlining operations and focusing resources on priority industry segments and products. Non-GAAP operating expenses* declined sequentially in the fourth quarter to $27.3 million, representing a reduction of more than 16% relative to the previously identified baseline of approximately $32.5 million, which reflects second quarter 2025 operating expenses adjusted to include a full quarter of Markforged. This reduction highlights the substantial execution of the Company’s previously announced cost reduction initiatives, with the full benefits expected to be realized in early 2026. The Company continues to evaluate additional opportunities to enhance operational performance and believes these initiatives position it to drive improved operating leverage over time.
  • Re-domestication and U.S. Reporting Transition: Effective January 1, 2026, Nano Dimension began reporting as a U.S. domestic issuer. The Company filed its Form 10-K today and anticipates completing the re-domestication process in the first half of 2026, subject to customary approvals. This transition aligns the Company’s reporting and governance framework with U.S. market standards while enhancing transparency for shareholders.
  • Share Repurchases and Capital Allocation: During 2025, the Company remained disciplined in capital allocation while preserving balance sheet strength and strategic flexibility. In the fourth quarter, the Company repurchased approximately 10.9 million shares for approximately $19.2 million under its existing $150 million authorization. Given the ongoing strategic alternatives review process, the Board is carefully evaluating capital deployment priorities and will not be providing forward-looking updates regarding repurchase activity at this time.
  • Strategic Alternatives Review: The Board, with the support of Guggenheim Securities, LLC and Houlihan Lokey, has conducted a thorough and disciplined review of strategic alternatives, evaluating product lines, core technologies, market dynamics and competitive positioning. The Company has made meaningful progress, including reducing losses and improving its product portfolio, while recognizing that a gap remains to achieving sustained profitability. Nano Dimension expects to announce a series of actions in the second quarter of 2026 to clearly define its path forward to maximizing shareholder value.

* More information, including a reconciliation of non-GAAP operating expenses to the most directly comparable GAAP financial measure can be found below in this press release under “Non-GAAP Financial Measures” and “Reconciliation of US GAAP to Non-GAAP Measures.”

2026 Financial Guidance

Following improved visibility exiting 2025 and continued integration of Markforged, the Company is implementing annual financial guidance beginning in 2026 to better reflect the mix of recurring revenue and larger strategic orders that can create quarterly variability.

For the full year 2026, the Company anticipates revenue in the range of $130 million to $140 million, non-GAAP gross margin of 46% to 48%, non-GAAP operating expenses of $106 million to $111 million and Adjusted EBITDA loss in the range of $40 million to $50 million.

Non-GAAP gross margin, non-GAAP operating expenses and Adjusted EBITDA represent non-GAAP financial measures. Additional information can be found below in this press release under “Non-GAAP Financial Measures.”

Conference Call Today

Nano Dimension will host a conference call today at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year ended December 31, 2025.

Participants can pre-register for the conference call in order to receive dial in information via this link: https://dpregister.com/sreg/10206850/10359dca11a

Participants can also dial-in/connect by following the below:

Listen in via U.S. dial-in: 1-844-695-5517
Listen via international dial-in: 1-412-902-6751
Listen via Israel toll free: 1-80-9212373
Listen via webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=1YPvoqSL

For those unable to participate in the conference call, there will be a replay available from a link on Nano Dimension’s website at https://investors.nano-di.com/events-and-presentations.

About Nano Dimension Ltd.

Driven by strong trends in onshoring, national security, and increasing product customization, Nano Dimension Ltd. (Nasdaq: NNDM) delivers advanced Digital Manufacturing technologies to the defense, aerospace, automotive, electronics, and medical devices industries, enabling rapid deployment of high-mix, low-volume production with IP security and sustainable manufacturing practices. For more information, please visit https://www.nano-di.com/.

Non-GAAP Financial Measures

EBITDA is a non-GAAP measure and is defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization. We believe that EBITDA should be useful in evaluating the performance of our business and operations. EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting interest expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively) and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to the items mentioned above.

Adjusted EBITDA and operating expenses are non-GAAP measures and are defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization, share-based compensation expense, exchange rate differences, finance expenses (income) for revaluation of assets and liabilities, Desktop Metal litigation related expenses, Desktop Metal and Markforged transaction related expenses, restructuring costs, impact of deconsolidation, impairment losses, litigation settlements and step-up amortization from purchase accounting. We believe that Adjusted EBITDA and operating expenses, as described above, should also be useful in evaluating the performance of our business. Like EBITDA, Adjusted EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting other financial expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from share-based payments, restructuring costs, impairment losses, and step-up amortization from purchase accounting. Adjusted EBITDA and operating expenses are useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to non-cash items, such as expenses related to share-based payments.

Adjusted gross profit, excluding depreciation and amortization, share-based compensation expenses, and step-up amortization from purchase accounting, is a non-GAAP measure. We believe that adjusted gross profit, as described above, should also be useful in evaluating the performance of our business. Adjusted gross profit facilitates gross profit and gross margin comparisons from period to period and company to company by backing out potential differences caused by variations in amortization of inventory and intangible assets. Adjusted gross profit is useful to an investor in evaluating our performance because it enables investors, securities analysts and other interested parties to measure a company’s performance without regard to non-cash items, such as amortization expenses. Adjusted gross margin is calculated by dividing the adjusted gross profit by the revenues.

EBITDA and Adjusted EBITDA, Adjusted gross profit and non-GAAP operating expenses can be useful in evaluating our performance by eliminating the effect of financing and non-cash expenses such as share-based payments, however, we may incur such expenses in the future, which could impact future results. In addition, other companies, including companies in our industry, may calculate non-GAAP metrics differently or not at all, which may reduce the usefulness of this measure as a tool for comparison.

Nano Dimension does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures due to the inherent difficulty in forecasting and quantifying certain significant items. These items are uncertain, depend on various factors and could have a material impact on GAAP reported results for the relevant period.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding Nano’s future growth, strategic plan and value to shareholders, and all other statements other than statements of historical fact that address activities, events or developments that Nano intends, expects, projects, believes or anticipates will or may occur in the future. Forward-looking statements may be characterized by terminology such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. Such statements are based on management’s beliefs and assumptions made based on information currently available to management. These forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company’s actual results and performance to be materially different from those expressed or implied in the forward-looking statements. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. Because such statements deal with future events and are based on the current expectations of Nano, they are subject to various risks and uncertainties. The forward-looking statements contained or implied in this communication are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Nano’s annual report on Form 20-F filed with the Securities and Exchange Commission (the “SEC”) on May 12, 2025, and in any subsequent filings with the SEC. Except as otherwise required by law, Nano undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this communication.

Contacts:

Investors: Purva Sanariya
Director, Investor Relations
ir@nano-di.com

Media: Samuel Manning
Principal Manager, External Communications
press@nano-di.com

       
NANO DIMENSION LTD.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data) (audited)
       
    December 31,  
    2025     2024  
Assets            
Current assets:            
Cash and cash equivalents   $ 204,672     $ 317,169  
Bank deposits     168,997       440,790  
Marketable equity securities     84,154        
Restricted bank deposits     123       537  
Trade receivables, net of allowance for doubtful accounts ($861 and $811, respectively)     26,047       9,141  
Inventory     32,878       16,899  
Other current assets     8,938       4,790  
Total current assets     525,809       789,326  
Restricted bank deposits     1,610       768  
Marketable equity securities           86,190  
Property, plant and equipment, net     24,840       14,143  
Operating lease right-of-use assets     23,789       9,958  
Deferred tax assets     424        
Goodwill     40,388        
Intangible assets, net     19,434       2,155  
Other assets     1,930        
Total assets   $ 638,224     $ 902,540  
Liabilities and Equity            
Current liabilities:            
Trade payables   $ 11,999     $ 4,249  
Accrued liabilities     19,514       18,771  
Deferred revenue     11,873       3,523  
Current portion of lease liability     8,923       3,421  
Current portion of bank loan     158       138  
Total current liabilities     52,467       30,102  
Employee benefits     3,697       4,700  
Operating lease right-of-use liabilities     23,323       6,707  
Bank loan     158       276  
Long-term settlement payable     2,974        
Long-term deferred revenue     3,617        
Total liabilities     86,236       41,785  
Commitments and contingencies            
Non-controlling interests           715  
Equity:            
Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 206,811,875 and 215,777,000 shares outstanding as of December 31, 2025 and December 31, 2024, respectively, and 279,306,522 and 273,847,185 shares issued as of December 31, 2025 and December 31, 2024, respectively.     417,084       409,145  
Additional paid-in capital     1,297,323       1,297,348  
Treasury stock     (192,507 )     (167,651 )
Accumulated other comprehensive income (loss)     1,048       (1,137 )
Accumulated loss     (970,960 )     (677,665 )
Total equity attributable to common shareholders     551,988       860,040  
Total equity     551,988       860,755  
Total liabilities and equity   $ 638,224     $ 902,540  
                 


NANO DIMENSION LTD.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data) (audited)
       
    For the Year Ended December 31,  
    2025(1)     2024     2023  
Revenue:                  
Product   $ 80,385     $ 45,557     $ 47,231  
Service     22,052       12,218       9,083  
Total revenue     102,437       57,775       56,314  
Cost of revenue:                  
Product     57,923       26,308       23,358  
Service     10,169       6,578       6,898  
Total cost of revenue     68,092       32,886       30,256  
Gross profit     34,345       24,889       26,058  
Operating expenses:                  
Research and development     30,054       39,558       65,146  
Sales and marketing     35,713       27,657       34,258  
General and administrative     59,766       45,987       55,973  
Restructuring     7,581              
Desktop Metal litigation     31,046              
Impairment losses     10,516       1,283        
Operating loss     (140,331 )     (89,596 )     (129,319 )
(Loss) gain on investment in marketable equity securities     (2,036 )     (52,256 )     23,462  
Other (expense) income, net     (479 )     486       1,627  
Finance income     35,400       42,573       47,584  
Finance expense     (111 )     (668 )     (367 )
Loss before income taxes     (107,557 )     (99,461 )     (57,013 )
Income tax benefit (expense)     7,202       (397 )     (62 )
Net loss from continuing operations     (100,355 )     (99,858 )     (57,075 )
Net loss from discontinued operations, net of income tax of nil     (193,263 )            
Net loss     (293,618 )     (99,858 )     (57,075 )
Less: Net loss attributable to non-controlling interests     (323 )     (1,029 )     (1,110 )
Net loss attributable to common shareholders   $ (293,295 )   $ (98,829 )   $ (55,965 )
                   
Net loss attributable to common shareholders:                  
Continuing operations - basic and diluted   $ (0.46 )   $ (0.45 )   $ (0.23 )
Discontinued operations - basic and diluted   $ (0.90 )   $     $  
                   
Weighted average common shares outstanding, basic and diluted     215,742       218,311       248,019  
Net loss   $ (293,618 )   $ (99,858 )   $ (57,075 )
Other comprehensive income (loss):                  
Foreign currency translation adjustment     1,791       (1,944 )     2,368  
Remeasurement of pension and post-employment benefit plans, net of tax     312       (2,769 )     (1,920 )
Comprehensive loss     (291,515 )     (104,571 )     (56,627 )
Less: Comprehensive loss attributable to non-controlling interests     (323 )     (1,088 )     (1,088 )
Comprehensive loss attributable to common shareholders   $ (291,192 )   $ (103,483 )   $ (55,539 )

(1) The results for the year ended December 31, 2025 include the consolidation of Markforged revenue of $54.3 million, gross profit of $13.3 million, and GAAP net loss of $30.0 million.

NANO DIMENSION LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands) (audited)
       
    For the Year Ended December 31,  
    2025     2024     2023  
Cash flow from operating activities                  
Net loss from continuing operations   $ (100,355 )   $ (99,858 )   $ (57,075 )
Adjustments:                  
Depreciation, amortization and non-cash lease interest     20,455       2,642       1,972  
Impairment losses     10,516       1,350       326  
Changes in fair value of equity securities     2,037       52,256       (23,462 )
Loss from deconsolidation of subsidiaries     1,666              
Share-based compensation expense     4,930       15,721       22,110  
Changes in assets and liabilities:                  
Decrease (increase) in inventory     5,596       387       (340 )
(Increase) decrease in other current assets     (175 )     6,078       (5,775 )
(Increase) decrease in trade receivables     (1,535 )     2,950       (5,603 )
Increase in deferred tax assets     (7,456 )           (11 )
(Decrease) increase in other payables     (9,993 )     (1,150 )     4,856  
(Decrease) increase in employee benefits     (1,393 )     (562 )     (1,478 )
Increase in trade payables     6,866       47       1,089  
Other     (1,426 )     1,218       (5,266 )
Net cash used in operating activities     (70,267 )     (18,921 )     (68,657 )
Cash flow relating to investing activities                  
Change in bank deposits     270,755       100,530       (189,060 )
Purchase of property plant and equipment     (1,064 )     (2,196 )     (9,098 )
Acquisition of intangible asset           (711 )     (1,524 )
Acquisition of subsidiaries, net of cash acquired     (267,816 )            
Deconsolidation of subsidiaries     (476 )            
Other                 835  
Net cash from (used in) investing activities     1,399       97,623       (198,847 )
Cash flow relating to financing activities                  
Repayment long-term bank debt     (149 )     (180 )     (536 )
Proceeds from non-controlling interests           555       1,089  
Payment of a liability for contingent consideration in a business combination                 (9,255 )
Payments of share price protection recognized in business combination           (363 )     (4,459 )
Repurchase of treasury shares     (24,856 )     (69,755 )     (96,387 )
Net cash used in financing activities     (25,005 )     (69,743 )     (109,548 )
Cash flow relating to discontinued operations                  
Net cash used in operating activities     (31,017 )            
Net cash used in investing activities     (437 )            
Net cash provided by financing activities     10,009              
Net cash used in discontinued operations     (21,445 )            
(Decrease) increase in cash, cash equivalents and restricted cash     (115,318 )     8,959       (377,052 )
Effect of exchange rate fluctuations on cash     3,249       (997 )     1,292  
Cash, cash equivalents and restricted cash at beginning of the year     318,474       310,512       686,272  
Cash, cash equivalents and restricted cash at end of the year   $ 206,405     $ 318,474     $ 310,512  
                   
Supplemental disclosures of cash flow information                  
Cash and cash equivalents   $ 204,672       317,169       309,571  
Restricted cash in restricted deposits, current     123       537       60  
Restricted cash in restricted deposits, non-current     1,610       768       881  
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows   $ 206,405     $ 318,474     $ 310,512  
                   
Non-cash operating activity                  
Intangible asset acquired on credit                 711  
Property plant and equipment acquired on credit     17       69       214  
Lease liabilities arising from obtaining right-of-use assets     1,167       1,275       929  
Non-cash investing activity                  
Acquisition replacement awards for pre-combination service     2,055              
Supplemental disclosure of cash flow information                  
Income taxes paid during the year     115       314       136  
                         


NANO DIMENSION LTD.
RECONCILIATION OF US GAAP TO NON-GAAP MEASURES
(In thousands)
                         
  Three Months Ended
December 31,
  Year Ended
December 31,
 
  2025     2024   2025     2024  
GAAP Net loss from continuing operations $ (33,942 )   $ (9,333 ) $ (100,355 )   $ (99,858 )
Tax expense (benefit)   (7,325 )     319     (7,202 )     397  
Depreciation and amortization     2,407       772       7,433       2,642  
Interest expense     543             971        
Interest income     (4,503 )     (10,092 )     (24,636 )     (42,573 )
Non-GAAP EBITDA (loss)     (42,820 )     (18,334 )     (123,789 )     (139,392 )
Finance expenses (income) from revaluation of assets and liabilities     24,431       (5,583 )     2,056       52,344  
Exchange rate differences     (2,264 )     (2,150 )     (10,764 )     485  
Share-based payments expense     1,912       3,213       4,930       15,721  
Desktop Metal litigation related expenses     138             31,046        
Desktop Metal and Markforged transaction related expenses     106       3,010       10,614       6,452  
Restructuring costs     532             7,581        
Impairment losses     2,110       1,283       10,516       1,283  
Acquisition inventory step-up amortization     3,209             10,661        
Litigation settlements and contingencies     3,521             4,621        
Other non-GAAP     (711 )     (371 )     (711 )     (486 )
Non-GAAP Adjusted EBITDA from continuing operations $ (9,836 )   $ (18,932 ) $ (53,239 )   $ (63,593 )
                         
               
  Three Months Ended
December 31,
  Year Ended
December 31,
 
Non-GAAP Cost of Revenue 2025     2024   2025     2024  
GAAP Cost of revenue $ 21,998     $ 9,775   $ 68,092     $ 32,886  
Share-based payments expense   172       228     669       938  
Depreciation and amortization     856       266     2,400       374  
Acquisition inventory step-up amortization     3,209             10,661        
Non-GAAP Cost of revenue   $ 17,761     $ 9,281     $ 54,362     $ 31,574  
                         
  Three Months Ended
December 31,
  Year Ended
December 31,
 
Non-GAAP Gross Profit 2025     2024   2025     2024  
GAAP Gross profit $ 13,317     $ 4,794   $ 34,345     $ 24,889  
Share-based payments expense   172       228     669       938  
Depreciation and amortization     856       266     2,400       374  
Acquisition inventory step-up amortization     3,209             10,661        
Non-GAAP Gross profit   $ 17,554     $ 5,288     $ 48,075     $ 26,201  
                         
  Three Months Ended
December 31,
  Year Ended
December 31,
 
Non-GAAP Research and Development Expenses 2025     2024   2025     2024  
GAAP Research and development expenses $ 7,466     $ 9,449   $ 30,054     $ 39,558  
Share-based payments expense   454       1,215     1,708       6,079  
Depreciation and amortization     424       493     1,432       1,355  
Non-GAAP Research and development expenses   $ 6,588     $ 7,741     $ 26,914     $ 32,124  
                         
  Three Months Ended
December 31,
  Year Ended
December 31,
 
Non-GAAP Sales and Marketing Expenses 2025     2024   2025     2024  
GAAP Sales and marketing expenses $ 10,065     $ 6,504   $ 35,713     $ 27,657  
Share-based payments expense   208       274     896       1,649  
Depreciation and amortization     769       143     2,221       518  
Non-GAAP Sales and marketing expenses   $ 9,088     $ 6,087     $ 32,596     $ 25,490  
                         
                         
  Three Months Ended
December 31,
  Year Ended
December 31,
 
Non-GAAP General and Administrative Expenses 2025     2024   2025     2024  
GAAP General and administrative expenses $ 16,681     $ 14,743   $ 59,766     $ 45,987  
Share-based payments expense   1,078       1,496     1,657       7,055  
Depreciation and amortization     358       (130 )   1,380       395  
Desktop Metal and Markforged transaction related expenses     106       3,010       10,614       6,452  
Other non-GAAP                       (115 )
Litigation settlements and contingencies     3,521             4,621        
Non-GAAP General and administrative expenses   $ 11,618     $ 10,367     $ 41,494     $ 32,200  
                         
  Three Months Ended
December 31,
  Year Ended
December 31,
 
Non-GAAP Operating Loss 2025     2024   2025     2024  
GAAP Operating loss $ (23,675 )   $ (27,185 ) $ (140,331 )   $ (89,596 )
Share-based payments expense   1,912       3,213     4,930       15,721  
Depreciation and amortization     2,407       772     7,433       2,642  
Desktop Metal litigation related expenses     138             31,046        
Desktop Metal and Markforged transaction related expenses     106       3,010       10,614       6,452  
Restructuring costs     532             7,581        
Impairment losses     2,110       1,283       10,516       1,283  
Acquisition inventory step-up amortization     3,209             10,661        
Litigation settlements and contingencies     3,521             4,621        
Other non-GAAP                       (115 )
Non-GAAP Operating loss   $ (9,740 )   $ (18,907 )   $ (52,929 )   $ (63,613 )
                                 



Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions